These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35870760)

  • 1. Gelation switch of polyamorphic indomethacin depending on the thermal procedure.
    Shen P; Zhang C; Hu E; Pang Z; Gao Y; Qian S; Zhang J; Wei Y; Heng W
    Eur J Pharm Biopharm; 2022 Aug; 177():249-259. PubMed ID: 35870760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gel Formation Induced Slow Dissolution of Amorphous Indomethacin.
    Heng W; Wei Y; Xue Y; Cheng H; Zhang L; Zhang J; Gao Y; Qian S
    Pharm Res; 2019 Sep; 36(11):159. PubMed ID: 31515697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX; Anderson BD
    J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulation of amorphous indomethacin.
    Xiang TX; Anderson BD
    Mol Pharm; 2013 Jan; 10(1):102-14. PubMed ID: 23116319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution-permeation of hot-melt extruded amorphous solid dispersion comprising an experimental grade of HPMCAS.
    Tanaka H; Miyano T; Ueda H
    ADMET DMPK; 2023; 11(3):373-385. PubMed ID: 37829323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the physical stability of amorphous indomethacin by mixing it with octaacetylmaltose. inter and intra molecular studies.
    Kaminska E; Adrjanowicz K; Zakowiecki D; Milanowski B; Tarnacka M; Hawelek L; Dulski M; Pilch J; Smolka W; Kaczmarczyk-Sedlak I; Kaminski K
    Pharm Res; 2014 Oct; 31(10):2887-903. PubMed ID: 24831310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
    Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch between Cocrystal and Coamorphous Forms Depending on Thermal Modulation of Hot-Melt Extrusion.
    Shen P; Zhang C; Hu E; Gao Y; Wei Y; Zhang J; Qian S; Heng W
    Mol Pharm; 2023 Jul; 20(7):3412-3426. PubMed ID: 37253085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.
    Thakral S; Suryanarayanan R
    Pharm Res; 2015 Nov; 32(11):3722-31. PubMed ID: 26063046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Physical Stability and Synchronized Release of Febuxostat and Indomethacin in Coamorphous Solids.
    Moinuddin SM; Shi Q; Tao J; Guo M; Zhang J; Xue Q; Ruan S; Cai T
    AAPS PharmSciTech; 2020 Jan; 21(2):41. PubMed ID: 31898765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T
    Okada K; Hirai D; Hayashi Y; Kumada S; Kosugi A; Onuki Y
    Chem Pharm Bull (Tokyo); 2019; 67(6):580-586. PubMed ID: 31155564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
    Crowley KJ; Zografi G
    Pharm Res; 2003 Sep; 20(9):1417-22. PubMed ID: 14567636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of processing route on the surface properties of amorphous indomethacin measured by inverse gas chromatography.
    Burnett DJ; Khoo J; Naderi M; Heng JY; Wang GD; Thielmann F
    AAPS PharmSciTech; 2012 Dec; 13(4):1511-7. PubMed ID: 23135965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-plasticizing effect of amorphous indomethacin induced by specific intermolecular interactions with PVA copolymer.
    Ueda H; Aikawa S; Kashima Y; Kikuchi J; Ida Y; Tanino T; Kadota K; Tozuka Y
    J Pharm Sci; 2014 Sep; 103(9):2829-2838. PubMed ID: 24890320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano-scale and molecular-level understanding of wet-milled indomethacin/poloxamer 407 nanosuspension with TEM, suspended-state NMR, and Raman measurements.
    Kuroiwa Y; Higashi K; Ueda K; Yamamoto K; Moribe K
    Int J Pharm; 2018 Feb; 537(1-2):30-39. PubMed ID: 29246438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of surface crystallisation of amorphous indomethacin particles in physical drug-polymer mixtures.
    Priemel PA; Laitinen R; Barthold S; Grohganz H; Lehto VP; Rades T; Strachan CJ
    Int J Pharm; 2013 Nov; 456(2):301-6. PubMed ID: 24012867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ amorphisation of indomethacin with Eudragit® E during dissolution.
    Priemel PA; Laitinen R; Grohganz H; Rades T; Strachan CJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1259-65. PubMed ID: 24056054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.